Azithromycin therapy reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction: Potential therapeutic targets in ischemic heart disease

INTRODUCTION: Acute myocardial infarction (MI) is a primary cause of worldwide morbidity and mortality. Macrophages are fundamental components of post-MI inflammation. Pro-inflammatory macrophages can lead to adverse cardiac remodeling and heart failure while anti-inflammatory/reparative macrophages...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Darraji, Ahmed, Haydar, Dalia, Chelvarajan, Lakshman, Tripathi, Himi, Levitan, Bryana, Gao, Erhe, Venditto, Vincent J., Gensel, John C., Feola, David J., Abdel-Latif, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042749/
https://www.ncbi.nlm.nih.gov/pubmed/30001416
http://dx.doi.org/10.1371/journal.pone.0200474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042749/
https://www.ncbi.nlm.nih.gov/pubmed/30001416
http://dx.doi.org/10.1371/journal.pone.0200474

Ejemplares similares